Gene expression after vaccination of mice with formulations of diphtheria toxoid or tetanus toxoid and different adjuvants: Identification of shared and vaccine-specific genes in spleen lymphocytes

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2307-2317

  Regnström, Karin ^a   Ragnarsson, Eva ^a   Artursson, Per ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Biomarkers; Gene expression; Vaccine

Indexed keywords

ALUMINUM PHOSPHATE; BIOLOGICAL MARKER; DIPHTHERIA TOXOID; FREUND ADJUVANT; TETANUS TOXOID;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN LYMPHOCYTE; VACCINATION;

EID: 0038403585     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00103-8     Document Type: Article

References (23)

1. Robbins F.C., Robbins J.B. Current status and prospects for some improved and new bacterial vaccines. Am. J. Public Health. 7:1986;105-125.
2. Edelman R. Vaccine adjuvants. Rev. Infect. Dis. 2(3):1980;370-383.
3. Hendriksen C.F., vd Gun J.W., Nagel J., Kreeftenberg J.G. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. J. Biol. Stand. 16(4):1988;287-297.
4. Regnström K., Ragnarsson E.G.E., Rydell N., Sjöholm I., Artursson P. Tetanus antigen modulates the gene expression profile of aluminum phosphate in spleen lymphocytes in vivo. Pharmacogenomics J. 2:2002;57-64.
5. Teague T.K., Hildeman D., Kedl R.M., Mitchell T., Rees W., Schaefer B.C.et al. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. U.S.A. 96(22):1999;12691-12696.
6. Tamayo P., Slonim D., Mesirov J., Zhu Q., Kitareewan S., Dmitrovsky E.et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. U.S.A. 96(6):1999;2907-2912.
7. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95(25):1998;14863-14868.
8. Lazaridis M. Course in statistical analysis of microarray studies. In: Proceedings of the 9th International Conference on Intelligent Systems for Molecular Biology, 2001 July; Copenhagen.
9. Möröy T., Grzeschiczek A., Petzold S., Hartmann K.U. Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10734-10738.
10. Domen J., vd Lugt N.M., Acton D., Laird P.W., Linders K., Berns A. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. J. Exp. Med. 178(5):1993;1665-1673.
11. Kvale D., Brandtzaeg P. Constitutive and cytokine induced expression of HLA molecules, secretory compononent, and intracellular adhesion molecule-1 is modulated by butyrate in the colonic epithelia cell line HT-29. Gut. 36(5):1995;737-742.
12. Avni O., Rao A. T cell differentiation: a mechanistic view. Curr. Opin. Immunol. 12:2000;654-659.
13. Saemann M.D., Bohmig G.A., Osterreicher C.H., Burtscher H., Parolini O., Diakos C.et al. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 14(15):2000;2380-2382.
14. Campanelli DPA, Detmers CF, Nathan, Gabay JE. J Clin Invest 1998;85:904-15.
15. Falk R.J., Jenette J.C. Wegener's granulomatosis, systemic vasculitis and antineutrophil cytoplasmic autoantibodies. Ann. Rev. Med. 42:1991;459-469.
16. Kurowsawa S., Esmon C.T., Stearns-Kurowsawa D.J. The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. J. Immunol. 165:2000;4697-4703.
17. Rook G.A.W., Ristori G., Salvetti M., Giovannoni G., Thompson E., Stanford J.L. Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseases. Immunol. Today. 21(10):2000;503-508.
18. Langst G., Blank T.A., Becker P.B., Grummt I. RNA polymerase I transcription on nucleosomal templates: the transcription termination factor TTF-1 induces chromatin remodeling and relieves transcriptional repression. EMBO J. 16(4):1997;760-768.
19. Evers R., Grummt I. Molecular co-evolution of mammalian ribosomal gene terminator sequences and the transcription termination factor TTF-I. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5827-5831.
20. Matzinger P. An innate sense of danger. Semin. Immunol. 10(5):1998;399-415.
21. Banks W.A., Kastin A.J., Fasold M.B. Differential effect of aluminum on the blood-brain barrier transport of peptides. J. Pharm. Exp. Ther. 244:1988;579-585.
22. Deleers M. Cationic atmosphere and cation competition binding at negative charged membranes. Pathological implications of aluminum. Res. Commun. Chem. Pharm. 49:1985;277-294.
23. Jensen T.K., Laegreid A., Komorowski J., Hovig E. A literature network of human genes for high-throughput analysis of gene expression. Nat. Genet. 28:2001;21-28.